A previous studyindicated that CDKN1 is an oncotarget in Burkitt lymphoma and MM.Currently, CDKN1 is more broadly considered to be a regulator offundamental cell-fate decisions such as proliferation, differentiation, and senescence(13). The gene discussed is CDKN1A; the disease is Miyoshi myopathy.